Nested Therapeutics
Dr. Carlo Rizzuto has served as a Director at Nested Therapeutics since Versant Ventures co-founded the company. As a Managing Director at Versant, he has been instrumental in establishing Versant’s presence in the Northeast and in building and investing in a number of Versant’s portfolio companies including Pandion (acquired), Repare (RPTX), Century (IPSC), Graphite (GRPH), Jnana, 858, and Stablix. Carlo joined Versant from Novartis, where he led global product development teams in their advancement of new medicines. Before that, Carlo served as the Associate Principal for McKinsey & company, where he advised international clients in the pharmaceutical, payor and provider sectors. Carlo earned a Ph.D. in Virology from Harvard University.
This person is not in the org chart
This person is not in any offices
Nested Therapeutics
Nested Therapeutics is a biotech company inspired by service and driven by a desire to make a meaningful impact. They are creative innovators who challenge their own assumptions as they strive to find new, overlooked areas of opportunity to design therapeutics for a perfect fit. They embrace diverse perspectives and experiences in a space for everyone to add value and be valued in return, with the purpose of building solutions together while having fun doing it.